Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhodiola rosea vs butylphthalide in very elderly patients with acute lacunar cerebral infarction
ChiCTR2500099109Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Vitano in lacunar infarct, ischemic stroke and Cerebral Small Vessel Disease (CSVD) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: New-onset acute cerebral infarction and National Institutes of Health Stroke Scale (NIHSS) score. Started Mar 2025; status: recruiting.
02
Drugs
Vitano
03
Conditions
lacunar infarctischemic strokeCerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on ChiCTR2500099109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099109.